PMID- 9300703 OWN - NLM STAT- MEDLINE DCOM- 19971008 LR - 20061115 IS - 0022-1767 (Print) IS - 0022-1767 (Linking) VI - 159 IP - 6 DP - 1997 Sep 15 TI - Early neutralizing antibody response against mouse mammary tumor virus: critical role of viral infection and superantigen-reactive T cells. PG - 2807-14 AB - Infectious mouse mammary tumor virus (MMTV) is a retrovirus that expresses a superantigen shortly after infection of B cells. The superantigen first drives the polyclonal activation and proliferation of superantigen-reactive CD4+ T cells, which then induce the infected B cells to proliferate and differentiate. Part of the MMTV-induced B cell response leads to the production of Abs that are specific for the viral envelope protein gp52. Here we show that this Ab response has virus-neutralizing activity and confers protection against superinfection by other MMTV strains in vivo as soon as 4 to 7 days after infection. A protective Ab titer is maintained lifelong. Viral infection as well as the superantigen-induced T-B collaboration are required to generate this rapid and long lasting neutralizing Ab response. Polyclonal or superantigen-independent B cell activation, on the contrary, does not lead to detectable virus neutralization. The early onset of this superantigen-dependent neutralizing response suggests that viral envelope-specific B cells are selectively recruited to form part of the extrafollicular B cell response and are subsequently amplified and maintained by superantigen-reactive Th cells. FAU - Luther, S A AU - Luther SA AD - Ludwig Institute for Cancer Research, Lausanne Branch, Switzerland. FAU - Maillard, I AU - Maillard I FAU - Luthi, F AU - Luthi F FAU - Scarpellino, L AU - Scarpellino L FAU - Diggelmann, H AU - Diggelmann H FAU - Acha-Orbea, H AU - Acha-Orbea H LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - J Immunol JT - Journal of immunology (Baltimore, Md. : 1950) JID - 2985117R RN - 0 (Antibodies, Viral) RN - 0 (Superantigens) SB - IM MH - Animals MH - Antibodies, Viral/*immunology MH - B-Lymphocytes/*immunology MH - CD4-Positive T-Lymphocytes/*immunology/virology MH - Immunity MH - Lymphocyte Activation/immunology MH - Mammary Tumor Virus, Mouse/*immunology MH - Mice MH - Mice, Inbred BALB C MH - Retroviridae Infections/*immunology MH - Superantigens/*immunology MH - Tumor Virus Infections/*immunology EDAT- 1997/09/23 00:00 MHDA- 1997/09/23 00:01 CRDT- 1997/09/23 00:00 PHST- 1997/09/23 00:00 [pubmed] PHST- 1997/09/23 00:01 [medline] PHST- 1997/09/23 00:00 [entrez] PST - ppublish SO - J Immunol. 1997 Sep 15;159(6):2807-14.